267 related articles for article (PubMed ID: 31059838)
1. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.
Gherardi RK; Crépeaux G; Authier FJ
Autoimmun Rev; 2019 Jul; 18(7):691-705. PubMed ID: 31059838
[TBL] [Abstract][Full Text] [Related]
2. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
Gherardi RK
Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
[TBL] [Abstract][Full Text] [Related]
3. [Biopersistence and systemic distribution of intramuscularly injected particles: what impact on long-term tolerability of alum adjuvants?].
Gherardi RK; Cadusseau J; Authier FJ
Bull Acad Natl Med; 2014 Jan; 198(1):37-48; discussion 49-53. PubMed ID: 26259285
[TBL] [Abstract][Full Text] [Related]
4. Macrophagic myofasciitis and vaccination: consequence or coincidence?
Santiago T; Rebelo O; Negrão L; Matos A
Rheumatol Int; 2015 Jan; 35(1):189-92. PubMed ID: 24923906
[TBL] [Abstract][Full Text] [Related]
5. Evidence Refuting the Existence of Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA).
Ameratunga R; Gillis D; Gold M; Linneberg A; Elwood JM
J Allergy Clin Immunol Pract; 2017; 5(6):1551-1555.e1. PubMed ID: 28888842
[TBL] [Abstract][Full Text] [Related]
6. Gulf war illness, post-HPV vaccination syndrome, and Macrophagic Myofasciitis. Similar disabling conditions possibly linked to vaccine-induced autoimmune dysautonomia.
Martinez-Lavin M; Tejada-Ruiz M
Autoimmun Rev; 2020 Sep; 19(9):102603. PubMed ID: 32659478
[TBL] [Abstract][Full Text] [Related]
7. Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study.
Ragunathan-Thangarajah N; Le Beller C; Boutouyrie P; Bassez G; Gherardi RK; Laurent S; Authier FJ
J Inorg Biochem; 2013 Nov; 128():262-6. PubMed ID: 23921285
[TBL] [Abstract][Full Text] [Related]
8. Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease.
Gherardi RK; Aouizerate J; Cadusseau J; Yara S; Authier FJ
Morphologie; 2016 Jun; 100(329):85-94. PubMed ID: 26948677
[TBL] [Abstract][Full Text] [Related]
9. Macrophagic myofasciitis: characterization and pathophysiology.
Gherardi RK; Authier FJ
Lupus; 2012 Feb; 21(2):184-9. PubMed ID: 22235051
[TBL] [Abstract][Full Text] [Related]
10. Polyglandular autoimmunity with macrophagic myofasciitis.
Theeler BJ; Simper NB; Ney JP
Clin Rheumatol; 2008 May; 27(5):667-9. PubMed ID: 18180978
[TBL] [Abstract][Full Text] [Related]
11. [Vaccine adjuvants and macrophagic myofasciitis].
Siegrist CA
Bull Acad Natl Med; 2003; 187(8):1511-8; discussion 1519-21. PubMed ID: 15146582
[TBL] [Abstract][Full Text] [Related]
12. Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.
Chkheidze R; Burns DK; White CL; Castro D; Fuller J; Cai C
J Neuropathol Exp Neurol; 2017 Apr; 76(4):323-331. PubMed ID: 28340105
[TBL] [Abstract][Full Text] [Related]
13. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.
Exley C; Swarbrick L; Gherardi RK; Authier FJ
Med Hypotheses; 2009 Feb; 72(2):135-9. PubMed ID: 19004564
[TBL] [Abstract][Full Text] [Related]
14. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
Gherardi RK; Coquet M; Cherin P; Belec L; Moretto P; Dreyfus PA; Pellissier JF; Chariot P; Authier FJ
Brain; 2001 Sep; 124(Pt 9):1821-31. PubMed ID: 11522584
[TBL] [Abstract][Full Text] [Related]
15. Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.
Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
Clin Rev Allergy Immunol; 2011 Oct; 41(2):163-8. PubMed ID: 20882368
[TBL] [Abstract][Full Text] [Related]
16. Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA.
Cadusseau J; Ragunathan-Thangarajah N; Surenaud M; Hue S; Authier FJ; Gherardi RK
Curr Med Chem; 2014; 21(4):511-7. PubMed ID: 24083602
[TBL] [Abstract][Full Text] [Related]
17. Macrophagic myofasciitis: a summary of Dr. Gherardi's presentations.
Brenner A
Vaccine; 2002 May; 20 Suppl 3():S5-6. PubMed ID: 12184366
[TBL] [Abstract][Full Text] [Related]
18. Macrophagic myofasciitis in childhood: the role of scanning electron microscopy/energy-dispersive spectroscopy for diagnosis.
Kalil RK; Monteiro A; Lima MI; Silveira EB; Foltran FS; Martins CE; Rizzo IM
Ultrastruct Pathol; 2007; 31(1):45-50. PubMed ID: 17455097
[TBL] [Abstract][Full Text] [Related]
19. Macrophagic myofasciitis-associated dysfunctioning: An update of neuropsychological and neuroimaging features.
Aoun Sebaiti M; Abrivard M; Blanc-Durand P; Van Der Gucht A; Souvannanorath S; Kauv P; Gherardi RK; Itti E; Authier FJ
Best Pract Res Clin Rheumatol; 2018 Oct; 32(5):640-650. PubMed ID: 31203922
[TBL] [Abstract][Full Text] [Related]
20. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants.
Shoenfeld Y; Agmon-Levin N
J Autoimmun; 2011 Feb; 36(1):4-8. PubMed ID: 20708902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
